VIDA Mobile Health Cardiovascular Prevention Program
Completed · Not applicable
Conditions studied: Coronary Artery Disease
In brief
The purpose of this study is to understand the effects of a mobile health cardiovascular prevention program in patients who have recently graduated from cardiac rehabilitation. The mobile health program will focus on promoting healthy lifestyles through the use of a mobile application (app), mobile physical activity monitor and a system of remote health coaching. By testing a novel mHealth intervention focused on lifestyle modification, this trial will address a critical evidence gap in the care of patients after they graduate from CR. Many patients who graduate from traditional CR struggle with unhealthy lifestyles, and these patients currently have no lifestyle-based care strategies to help them. The results of this study have the potential to lead to new sustainable and resource-efficient, lifestyle-based preventive care strategies for patients with stable CVD.
Key facts
- Study ID
- NCT02431546
- Run by
- Duke University
- People needed
- 34
- Starts
- 2015-07-01
- Expected to finish
- 2017-03-20
- Last updated by the study team
- 2018-02-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Graduates of CR, who were originally enrolled in CR following myocardial infarction (MI), percutaneous coronary intervention (PCI), or coronary artery bypass graft (CABG) or with stable angina
- Adequate clinical stability has been achieved in the judgment of the investigator to allow participation in study assessments and the intervention
- Ability to participate in a mobile health program with access to smartphones utilizing Apple and Android platforms
- Signed informed consent document indicating that the patient understands the purpose of and procedures required for the study and is willing to participate in the study
You may not qualify if…
- Acute symptoms of coronary artery disease
- Decompensated heart failure
- Severe valvular heart disease
- Severe pulmonary hypertension
- End stage renal disease
- Heart failure, New York Heart Association (NYHA) class IV
- Cardiac transplantation
- Terminal illness with life expectancy < 1 year
- Impairment from stroke, injury or other medical disorder that precludes participation in the intervention
- Dementia that precludes ability to participate in and follow study protocols
- Enrollment in a clinical trial not approved for co-enrollment
- Inability or unwillingness to comply with the study requirements
Where it is running
- Duke Medicine - Duke Molecular Physiology Institute — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.